The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intravenous (IV) Solution-Global Market Insights and Sales Trends 2024
Synopsis
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous (IV) Solution market size is expected to reach US$ 18440 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous (IV) Solution in various end use industries. The expanding demands from the Hospitals & Clinics, Ambulatory and Homecare,, are propelling Intravenous (IV) Solution market. Total Parenteral Solution, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Peripheral Parenteral Solution segment is estimated at % CAGR for the next seven-year period.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous (IV) Solution, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous (IV) Solution market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous (IV) Solution market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous (IV) Solution sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous (IV) Solution covered in this report include ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical and Grifols, etc.
The global Intravenous (IV) Solution market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Global Intravenous (IV) Solution market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous (IV) Solution market, Segment by Type:
Total Parenteral Solution
Peripheral Parenteral Solution
Global Intravenous (IV) Solution market, by Application
Hospitals & Clinics
Ambulatory
Homecare
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous (IV) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous (IV) Solution market size is expected to reach US$ 18440 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous (IV) Solution in various end use industries. The expanding demands from the Hospitals & Clinics, Ambulatory and Homecare,, are propelling Intravenous (IV) Solution market. Total Parenteral Solution, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Peripheral Parenteral Solution segment is estimated at % CAGR for the next seven-year period.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous (IV) Solution, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous (IV) Solution market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous (IV) Solution market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous (IV) Solution sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous (IV) Solution covered in this report include ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical and Grifols, etc.
The global Intravenous (IV) Solution market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Global Intravenous (IV) Solution market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous (IV) Solution market, Segment by Type:
Total Parenteral Solution
Peripheral Parenteral Solution
Global Intravenous (IV) Solution market, by Application
Hospitals & Clinics
Ambulatory
Homecare
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous (IV) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Intravenous (IV) Solution Market Overview
1.1 Intravenous (IV) Solution Product Overview
1.2 Intravenous (IV) Solution Market Segment by Type
1.2.1 Total Parenteral Solution
1.2.2 Peripheral Parenteral Solution
1.3 Global Intravenous (IV) Solution Market Size by Type
1.3.1 Global Intravenous (IV) Solution Market Size Overview by Type (2018-2029)
1.3.2 Global Intravenous (IV) Solution Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intravenous (IV) Solution Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intravenous (IV) Solution Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intravenous (IV) Solution Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intravenous (IV) Solution Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intravenous (IV) Solution Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intravenous (IV) Solution Sales Breakdown by Type (2018-2023)
2 Global Intravenous (IV) Solution Market Competition by Company
2.1 Global Top Players by Intravenous (IV) Solution Sales (2018-2023)
2.2 Global Top Players by Intravenous (IV) Solution Revenue (2018-2023)
2.3 Global Top Players by Intravenous (IV) Solution Price (2018-2023)
2.4 Global Top Manufacturers Intravenous (IV) Solution Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous (IV) Solution Market Competitive Situation and Trends
2.5.1 Intravenous (IV) Solution Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Solution Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2022)
2.7 Date of Key Manufacturers Enter into Intravenous (IV) Solution Market
2.8 Key Manufacturers Intravenous (IV) Solution Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravenous (IV) Solution Status and Outlook by Region
3.1 Global Intravenous (IV) Solution Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intravenous (IV) Solution Historic Market Size by Region
3.2.1 Global Intravenous (IV) Solution Sales in Volume by Region (2018-2023)
3.2.2 Global Intravenous (IV) Solution Sales in Value by Region (2018-2023)
3.2.3 Global Intravenous (IV) Solution Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intravenous (IV) Solution Forecasted Market Size by Region
3.3.1 Global Intravenous (IV) Solution Sales in Volume by Region (2024-2029)
3.3.2 Global Intravenous (IV) Solution Sales in Value by Region (2024-2029)
3.3.3 Global Intravenous (IV) Solution Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intravenous (IV) Solution by Application
4.1 Intravenous (IV) Solution Market Segment by Application
4.1.1 Hospitals & Clinics
4.1.2 Ambulatory
4.1.3 Homecare
4.2 Global Intravenous (IV) Solution Market Size by Application
4.2.1 Global Intravenous (IV) Solution Market Size Overview by Application (2018-2029)
4.2.2 Global Intravenous (IV) Solution Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intravenous (IV) Solution Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intravenous (IV) Solution Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intravenous (IV) Solution Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intravenous (IV) Solution Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intravenous (IV) Solution Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intravenous (IV) Solution Sales Breakdown by Application (2018-2023)
5 North America Intravenous (IV) Solution by Country
5.1 North America Intravenous (IV) Solution Historic Market Size by Country
5.1.1 North America Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intravenous (IV) Solution Sales in Volume by Country (2018-2023)
5.1.3 North America Intravenous (IV) Solution Sales in Value by Country (2018-2023)
5.2 North America Intravenous (IV) Solution Forecasted Market Size by Country
5.2.1 North America Intravenous (IV) Solution Sales in Volume by Country (2024-2029)
5.2.2 North America Intravenous (IV) Solution Sales in Value by Country (2024-2029)
6 Europe Intravenous (IV) Solution by Country
6.1 Europe Intravenous (IV) Solution Historic Market Size by Country
6.1.1 Europe Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intravenous (IV) Solution Sales in Volume by Country (2018-2023)
6.1.3 Europe Intravenous (IV) Solution Sales in Value by Country (2018-2023)
6.2 Europe Intravenous (IV) Solution Forecasted Market Size by Country
6.2.1 Europe Intravenous (IV) Solution Sales in Volume by Country (2024-2029)
6.2.2 Europe Intravenous (IV) Solution Sales in Value by Country (2024-2029)
7 Asia-Pacific Intravenous (IV) Solution by Region
7.1 Asia-Pacific Intravenous (IV) Solution Historic Market Size by Region
7.1.1 Asia-Pacific Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intravenous (IV) Solution Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intravenous (IV) Solution Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intravenous (IV) Solution Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravenous (IV) Solution Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intravenous (IV) Solution Sales in Value by Region (2024-2029)
8 Latin America Intravenous (IV) Solution by Country
8.1 Latin America Intravenous (IV) Solution Historic Market Size by Country
8.1.1 Latin America Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intravenous (IV) Solution Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intravenous (IV) Solution Sales in Value by Country (2018-2023)
8.2 Latin America Intravenous (IV) Solution Forecasted Market Size by Country
8.2.1 Latin America Intravenous (IV) Solution Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intravenous (IV) Solution Sales in Value by Country (2024-2029)
9 Middle East and Africa Intravenous (IV) Solution by Country
9.1 Middle East and Africa Intravenous (IV) Solution Historic Market Size by Country
9.1.1 Middle East and Africa Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intravenous (IV) Solution Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intravenous (IV) Solution Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intravenous (IV) Solution Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravenous (IV) Solution Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intravenous (IV) Solution Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ICU Medical
10.1.1 ICU Medical Company Information
10.1.2 ICU Medical Introduction and Business Overview
10.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ICU Medical Intravenous (IV) Solution Products Offered
10.1.5 ICU Medical Recent Development
10.2 B. Braun Melsungen
10.2.1 B. Braun Melsungen Company Information
10.2.2 B. Braun Melsungen Introduction and Business Overview
10.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.2.4 B. Braun Melsungen Intravenous (IV) Solution Products Offered
10.2.5 B. Braun Melsungen Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Intravenous (IV) Solution Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Baxter
10.4.1 Baxter Company Information
10.4.2 Baxter Introduction and Business Overview
10.4.3 Baxter Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter Intravenous (IV) Solution Products Offered
10.4.5 Baxter Recent Development
10.5 Amanta Healthcare
10.5.1 Amanta Healthcare Company Information
10.5.2 Amanta Healthcare Introduction and Business Overview
10.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amanta Healthcare Intravenous (IV) Solution Products Offered
10.5.5 Amanta Healthcare Recent Development
10.6 Terumo Medical
10.6.1 Terumo Medical Company Information
10.6.2 Terumo Medical Introduction and Business Overview
10.6.3 Terumo Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Medical Intravenous (IV) Solution Products Offered
10.6.5 Terumo Medical Recent Development
10.7 Grifols
10.7.1 Grifols Company Information
10.7.2 Grifols Introduction and Business Overview
10.7.3 Grifols Intravenous (IV) Solution Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Grifols Intravenous (IV) Solution Products Offered
10.7.5 Grifols Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravenous (IV) Solution Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravenous (IV) Solution Industrial Chain Analysis
11.4 Intravenous (IV) Solution Market Dynamics
11.4.1 Intravenous (IV) Solution Industry Trends
11.4.2 Intravenous (IV) Solution Market Drivers
11.4.3 Intravenous (IV) Solution Market Challenges
11.4.4 Intravenous (IV) Solution Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravenous (IV) Solution Distributors
12.3 Intravenous (IV) Solution Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
